Nausea is a very common and distressing problem. Some medications that treat nausea carry a higher risk for arrhythmias, like Torsades de Pointes, and sudden cardiac death. Is ondansetron safe for use in patients on hemodialysis?
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FIDELIO-DKD trial?
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) June 16, 2023
We bring to you today a treatment suggested (2B) by KDIGO to be beneficial in slowing eGFR decline of non-Transplant patients, and evaluate its evidence in the Tx cohort.
Does NaHCO3 Preserve-Transplant function? 🧵
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/vSgmerzo2o
Want to learn more about the latest in using plasma exchange in ANCA-associated vasculitis? (if you’re a nephrologist, of course you do!)
Check out this rapid summary below!
✳️ #TenTweetNephJC ✳️
— Nephrology Jrnl Club (@NephJC) April 8, 2022
👉 where we catch you up on the week's #NephJC chat in 10 tweets
The topic at hand was Plasma Exchange and Vasculitis: the infamous debate of to PLEX or not to PLEX in AAV
Check out this thread to see if you change your mind on this comPLEX topic 👇 pic.twitter.com/PvW0C0O9R9
Excellent visual abstract from Husam Alzayer, NSMC intern of the class of 2022
